The biological properties of iron oxide core high-density lipoprotein in experimental atherosclerosis

被引:61
作者
Skajaa, Torjus [1 ,2 ,3 ]
Cormode, David P. [1 ]
Jarzyna, Peter A. [1 ]
Delshad, Amanda [1 ]
Blachford, Courtney [4 ,5 ]
Barazza, Alessandra [4 ,5 ]
Fisher, Edward A. [4 ,5 ]
Gordon, Ronald E. [6 ]
Fayad, Zahi A. [1 ]
Mulder, Willem J. M. [1 ,7 ]
机构
[1] Mt Sinai Sch Med, Translat & Mol Imaging Inst, New York, NY 10029 USA
[2] Aarhus Univ Hosp Skejby, Inst Clin, DK-8200 Aarhus N, Denmark
[3] Aarhus Univ Hosp Skejby, Dept Cardiol, DK-8200 Aarhus N, Denmark
[4] NYU Sch Med, Dept Med Cardiol, New York, NY 10016 USA
[5] NYU Sch Med, Dept Cell Biol, New York, NY 10016 USA
[6] Mt Sinai Sch Med, Dept Pathol, New York, NY 10029 USA
[7] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA
基金
美国国家科学基金会;
关键词
High-density lipoprotein; Iron oxide nanoparticles; Transmission electron microscopy; Optical imaging; Nanoparticle excretion; APOLIPOPROTEIN-A-I; APOA-I; CHOLESTEROL EFFLUX; CONTRAST AGENT; MOUSE MODELS; HDL; NANOPARTICLES; PEPTIDE; PLAQUE; CELLS;
D O I
10.1016/j.biomaterials.2010.08.078
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Lipoproteins are a family of plasma nanoparticles responsible for the transportation of lipids throughout the body. High-density lipoprotein (HDL), the smallest of the lipoprotein family, measures 7-13 nm in diameter and consists of a cholesteryl ester and triglyceride core that is covered with a monolayer of phospholipids and apolipoproteins. We have developed an iron oxide core HDL nanoparticle (FeO-HDL), which has a lipid based fluorophore incorporated in the phospholipid layer. This nanoparticle provides contrast for optical imaging, magnetic resonance imaging (MRI) and transmission electron microscopy (TEM). Consequently, FeO-HDL can be visualized on the anatomical, cellular and sub-cellular level. In the current study we show that the biophysical features of FeO-HDL closely resemble those of native HDL and that FeO-HDL possess the ability to mimic HDL characteristics both in vitro as well as in vivo. We demonstrate that FeO-HDL can be applied to image HDL interactions and to investigate disease settings where HDL plays a key function. More generally, we have demonstrated a multimodal approach to study the behavior of biomaterials in vitro as well as in vivo. The approach allowed us to study nanoparticle dynamics in circulation, as well as nanoparticle targeting and uptake by tissues and cells of interest. Moreover, we were able to qualitatively assess nanoparticle excretion, critical for translating nanotechnologies to the clinic. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:206 / 213
页数:8
相关论文
共 30 条
  • [1] Identification of scavenger receptor SR-BI as a high density lipoprotein receptor
    Acton, S
    Rigotti, A
    Landschulz, KT
    Xu, SZ
    Hobbs, HH
    Krieger, M
    [J]. SCIENCE, 1996, 271 (5248) : 518 - 520
  • [2] High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions
    Barter, P
    Kastelein, J
    Nunn, A
    Hobbs, R
    [J]. ATHEROSCLEROSIS, 2003, 168 (02) : 195 - 211
  • [3] Mouse models of atherosclerosis
    Breslow, JL
    [J]. SCIENCE, 1996, 272 (5262) : 685 - 688
  • [4] Bruns OT, 2009, NAT NANOTECHNOL, V4, P193, DOI [10.1038/NNANO.2008.405, 10.1038/nnano.2008.405]
  • [5] Renal clearance of quantum dots
    Choi, Hak Soo
    Liu, Wenhao
    Misra, Preeti
    Tanaka, Eiichi
    Zimmer, John P.
    Ipe, Binil Itty
    Bawendi, Moungi G.
    Frangioni, John V.
    [J]. NATURE BIOTECHNOLOGY, 2007, 25 (10) : 1165 - 1170
  • [6] Nanocrystal Core High-Density Lipoproteins: A Multimodality Contrast Agent Platform
    Cormode, David P.
    Skajaa, Torjus
    van Schooneveld, Matti M.
    Koole, Rolf
    Jarzyna, Peter
    Lobatto, Mark E.
    Calcagno, Claudia
    Barazza, Alessandra
    Gordon, Ronald E.
    Zanzonico, Pat
    Fisher, Edward A.
    Fayad, Zahi A.
    Mulder, Willem J. M.
    [J]. NANO LETTERS, 2008, 8 (11) : 3715 - 3723
  • [7] An ApoA-I mimetic peptide high-density-lipoprotein-based MRI contrast agent for atherosclerotic plaque composition detection
    Cormode, David P.
    Briley-Saebo, Karen C.
    Mulder, Willem J. M.
    Aguinaldo, Juan Gilberto S.
    Barazza, Alessandra
    Ma, Yanqing
    Fisher, Edward A.
    Fayad, Zahi A.
    [J]. SMALL, 2008, 4 (09) : 1437 - 1444
  • [8] Datta G, 2001, J LIPID RES, V42, P1096
  • [9] DAVIDSON WS, 1994, J BIOL CHEM, V269, P22975
  • [10] Feig JE, 2008, CURR DRUG TARGETS, V9, P196